Laxaro

View the latest news and breaking news today

biomarker could lead to personalized therapies for prostate cancer - Search

biomarker could lead to personalized therapies for prostate cancer Searched from official sources arount the web with simple content and resource link From any languages in different countries.



biomarker could lead to personalized therapies for prostate cancer




columbia, mo. - in 2016, more than 181,000 new cases of prostate cancer were reported in the u.s., according to the american cancer society. the prostate-specific antigen (psa) test is one of the earliest ways clinicians can detect prostate cancers in their patients. sometimes, a high psa level may ...



combination immunotherapy effective for advanced prostate cancer




advanced prostate cancer resistant to castration therapy appears to respond well to a combination of immune checkpoint blockades and treatments that target certain immune-busting cells commonly associated with poor patient prognosis and therapy resistance.researchers at the university of texas md an...



are men with a family history of prostate cancer eligible for active surveillanc




active surveillance--careful monitoring to determine if or when a cancer warrants treatment--is an increasingly prevalent choice for prostate cancer, but it's unclear if the strategy is appropriate for men with a family history of prostate cancer. a recent analysis of the medical literature conclude...



new molecules may offer treatment option for some aggressive prostate cancers




orlando -- novel molecules called selective androgen receptor degraders (sards) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. the results of this research will be presented saturday, april 1, at endo 2017, the 99th annual mee...



genetic association with aggressive prostate cancer discovered




image: dr. alexandre zlotta led the study identifying a genetic association with aggressive prostate cancer. view more credit: courtesy of mount sinai hospital, toronto, canadamarch 16, 2017 (toronto) - an international study published in the journal of the national cancer institute has identified ...



fluciclovine pet/ct improves radiotherapy targeting for recurrent prostate cance




image: ctvpost (red) = ctvpre (yellow) union ctvpet (pink). also shown (upper right corner) are the pre (square) vs post (triangle) dose volume histograms for ptv1, ptv2, rectum, bladder, and penile... view more credit: ashesh b. jani, md, and david schuster, md, emory university.reston, va. (march...



castration-resistant prostate cancer cell growth impeded by endostatin




image: this is joo hyoung lee (left) and selvarangan ponnazhagen. view more credit: uabbirmingham, ala. - failure of hormone deprivation therapy, which is used to slow prostate cancer in patients, leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatmen...



two migration proteins boost predictive value of pancreatic cancer biomarker




image: this is ann killary, ph.d. view more credit: md anderson cancer centeradding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from the university of te...



clinical trial shows benefit of yoga for side effects of prostate cancer treatme




image: this is a penn yoga session. view more credit: penn medicinephiladelphia - men who attended a structured yoga class twice a week during prostate cancer radiation treatment reported less fatigue and better sexual and urinary function than those who didn't, according to a clinical trial led by...



non-invasive prostate cancer diagnosing, monitoring




ph.d. student parissa ziaei prepares silica nanosprings for a prostate cancer detection device in su ha's lab at the gene and linda voiland school of chemical engineering and bioengineering at wsu. credit: washington state universitytechnology being developed at washington state university provides ...



prostate screening often occurs without discussion of benefits, risks




a new study finds that while a blood test that helps to screen for prostate cancer remains common, only 30 percent of men in a large national survey reported having a balanced discussion of the advantages and disadvantages of the screening with their doctor. moreover, having such a discussion of bot...



penn studies find promise for innovations in liquid biopsies




image: this is a cluster of three circulating tumor cells. view more credit: penn medicinephiladelphia - from using fluid in the lungs to better understand the potential of immunotherapy treatments in lung cancer, to tracking circulating tumor cells in prostate cancer, to conducting rna sequencing ...



prostate cancer trial shows treating with precision radiotherapy cuts course of




image: this is dr. charles catton, radiation oncologist, princess margaret cancer centre, university health network. view more credit: uhn(toronto, canada - march 16, 2017) - an ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation t...



nonsurgical treatment for enlarged prostate remains effective for years




washington (march 8, 2017) -- a minimally invasive treatment that reduces urinary tract symptoms for men with enlarged prostates maintains its effectiveness for at least three years after patients undergo the therapy, according to research being presented at the society of interventional radiology's...



a new role for an old immune cell may lead to novel therapies for infection and




a new study has identified a previously undescribed role for a type of unconventional t cell with the potential to be used in the development of new therapies for infection and cancer.the study, published today in nature communications, shows that gamma delta t cells are able to generate immunologic...



pathology atlas to be previewed at aacr17




a demo version of a new pathology atlas will be presented on april 2-5 at the annual meeting of american association of cancer research (aacr17) in washington, dc. launched by the human protein atlas consortium in sweden, the new atlas provides researchers information about the relationship of expre...



newly discovered vulnerability in an aggressive breast cancer provides therapeut




triple-negative breast cancer quickly becomes resistant to current therapies, leaving patients no therapeutic options. bidmc researchers discovered that tnbc cells increase production of pyrimidine nucleotides in response to traditional chemotherapy. discovery represents a vulnerability that can be ...



race for life | riviera insider




now in its fourth year in the south of france, the annual charity race for cancer research uk – the race for life - will be taking place in the scenic parc de l’étang in mougins on 11th june. this year, the race will be raising money for three different types of cancer: breast cancer, prostate ...



new research explains why even targeted therapies eventually fail in lung cancer




cold spring harbor, ny - nearly 50 years into the "war" on cancer, doctors possess weapons that once would have seemed magical in their tumor-killing specificity. the drug tarceva (erlotinib), for example, can virtually erase all traces of aggressive lung cancer tumors in a subset of patients who be...



a biomarker for cancer of the oropharynx




cancer of the oropharynx has become increasingly common: in the united states alone, the number of newly diagnosed cases has tripled over the past three decades. about 70 percent of these tumors are caused by infection with human papillomavirus (hpv) type 16. tim waterboer and his colleagues at the ...



soy food consumption linked to prolonged survival in some breast cancer patients




new research indicates that dietary soy products are safe and even beneficial for women diagnosed with breast cancer. published early online in cancer, a peer-reviewed journal of the american cancer society, the findings may help resolve controversies over soy's potential link to breast cancer outco...



trial: abiraterone acetate responses even after initial hormone therapy failure




image: thomas flaig, md, is national primary investigator on clinical trial showing 13 percent response to abiraterone acetate in metastatic prostate cancer patients previously non-responding to hormone therapy view more credit: university of colorado cancer centerpatients with metastatic prostate ...



joe biden at sxsw: vows to work with donald trump on cancer




at the annual digital, music and entertainment festival in austin, tex., former vice president joe biden described how his role in heading up the white house moonshot on cancer came about — from a comment he made to former president obama that his only regret in not running for the presidency was ...



a light breakfast can cut some cancer drug doses, dutch researchers say




although pharmaceutical firms recommend that many anti-cancer drugs should be taken on an empty stomach, researchers at radboud teaching hospital in nijmegen say a light breakfast can actually reduce the need for high doses of medicine, the volkskrant reported on monday.the research project is one o...



penn researchers use new imaging to show key enzyme in ovarian cancer




philadelphia - a new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive. currently, epithelial ovarian cancer patients with brca1 mutations are considered candidates for the trea...